Breaking News Instant updates and real-time market news.

ORLY

O'Reilly Automotive

$228.03

3.31 (1.47%)

, CMG

Chipotle

$339.30

6.4 (1.92%)

19:00
04/25/18
04/25
19:00
04/25/18
19:00

On The Fly: After Hours Movers

UP AFTER EARNINGS: O'Reilly Automotive (ORLY) up 12.4%... Chipotle (CMG) up 10.5%... PCM Inc (PCMI) up 10.4%... Advanced Micro Devices (AMD) up 10.0%... Facebook (FB) up 7.5%... Echo Global Logistics (ECHO) up 5.9%... Xilinx (XLNX) up 5.4%... PayPal (PYPL) up 4.5%... Align Technology (ALGN) up 4.4%... Citrix (CTXS) up 3.7%... Visa (V) up 2.8%... CoreLogic (CLGX) up 2.8%... Ford (F) up 2.6%... Qualcomm (QCOM) up 1.8%... Las Vegas Sands (LVS) up 1.3%... Legg Mason (LM) up 0.9%. ALSO HIGHER: Intuit (INTU) up 3.3% after raising FY18 outlook based on TurboTax use update... Twitter (TWTR) up 2.0% after UBS upgrade. DOWN AFTER EARNINGS: FARO Technologies (FARO) down 12.6%... LaMaitre Vascular (LMAT) down 10.7%... Universal Health (UHS) down 5.8%... eBay (EBAY) down 4.5%... AT&T (T) down 4.5%... Kirby Corp (KEX) down 3.0%... Goldcorp (GG) down 1.8%... Biomarin (BMRN) down 1.4%.

ORLY

O'Reilly Automotive

$228.03

3.31 (1.47%)

CMG

Chipotle

$339.30

6.4 (1.92%)

PCMI

PCM, Inc.

$10.60

0.1 (0.95%)

AMD

AMD

$9.72

-0.37 (-3.67%)

FB

Facebook

$159.69

0.03 (0.02%)

ECHO

Echo Global

$27.80

0.15 (0.54%)

XLNX

Xilinx

$63.70

-0.34 (-0.53%)

PYPL

PayPal

$74.00

-1.29 (-1.71%)

ALGN

Align Technology

$245.24

5.72 (2.39%)

CTXS

Citrix

$96.54

0.04 (0.04%)

V

Visa

$121.00

-0.41 (-0.34%)

CLGX

CoreLogic

$43.85

-0.57 (-1.28%)

F

Ford

$11.11

0.16 (1.46%)

QCOM

Qualcomm

$49.77

-0.17 (-0.34%)

LVS

Las Vegas Sands

$72.42

-1.38 (-1.87%)

LM

Legg Mason

$37.64

0.25 (0.67%)

INTU

Intuit

$176.38

-2.25 (-1.26%)

TWTR

Twitter

$29.88

-0.6 (-1.97%)

FARO

FARO Technologies

$60.50

-1.85 (-2.97%)

LMAT

LeMaitre

$39.00

0.19 (0.49%)

UHS

Universal Health

$122.03

1.5 (1.24%)

EBAY

eBay

$40.98

-0.2 (-0.49%)

T

AT&T

$35.19

0.19 (0.54%)

KEX

Kirby

$82.95

-1.85 (-2.18%)

GG

Goldcorp

$13.97

-0.38 (-2.65%)

BMRN

BioMarin

$81.41

0.33 (0.41%)

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 30

    Apr

  • 01

    May

  • 01

    May

  • 02

    May

  • 02

    May

  • 08

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 10

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 12

    Jun

  • 27

    Jul

  • 12

    Sep

ORLY O'Reilly Automotive
$228.03

3.31 (1.47%)

04/23/18
WELS
04/23/18
INITIATION
Target $260
WELS
Outperform
O'Reilly Automotive initiated with an Outperform at Wells Fargo
Wells Fargo analyst Zachary Fadem initiated O'Reilly Automotives with an Outperform and $260 price target.
04/24/18
RBCM
04/24/18
NO CHANGE
Target $262
RBCM
Outperform
O'Reilly Automotive price target lowered to $262 from $286 at RBC Capital
RBC Capital analyst Scot Ciccarelli lowered his price target on O'Reilly Automotive, saying sales in Q1 were likely hurt by adverse weather, even though he expects trends to recover in Q2 and Q3. The analyst is also cautious on the Commercial segment which has been outpaced by the DIY over the past 18 months, citing the likelihood of reduced car sales in 2008-11 producing less cars entering their initial repair stages. Ciccarelli keeps his Outperform rating on O'Reilly Auto, but adds that investors will "need to be patient".
04/23/18
WELS
04/23/18
INITIATION
Target $205
WELS
Outperform
Home improvement and autopart retail offers favorable pockets, says Wells Fargo
As reported earlier, Wells Fargo analyst Zachary Fadem initiated select names within the home improvement, auto part retail, home furnishings, and specialty hardlines. The analyst notes that the pullback in some of these stocks related to "uncertainty around margins, global trade policy, and the sustainability of recently improving results", which replaced the enthusiasm from the anticipated consumer strength, rising wages, and tax reform benefits earlier this year, has produced some "compelling" long-term investment opportunities. Fadem initiated Home Depot (HD) and Lowe's (LOW) at Outperform with respective price targets of $205 and $100, saying home improvement is particularly attractive in retail today given the valuations in housing and demographics tailwinds. The analyst adds that the home improvement category has seen the most consistent growth in "consumer share of wallet" to 7.5% over the past 5 years, even though that level is still below 8.7% prior peak in 2005. Fadem's view on Bed Bath and Beyond (BBBY) is less upbeat with an Underperform rating and a $16 price target based on its limited growth opportunity, margin profile, differentiation, and e-commerce strategy. Similarly, the analyst profiles the auto parts retail offering some opportunity in terms of "lost share of wallet" sliding to 1.8%, below the 10-year average of 1.9%, while offering "attractive valuations" and an opportunity to regain its footing. Fadem initiates O'Reilly (ORLY) and AutoZone (AZO) with an Outperform rating and price targets of $260 and $700 respectively, adding that these two companies exceeded the industry growth even as auto parts retailers as a group trade at a 23% discount relative to the S&P500. The analyst also initiated select names in the Home Furnishings/Specialty categories, including At Home (HOME) at Outperform with a price target of $42, Tractor Supply (TSCO) at Outperform with a price target of $70, and National Vision (EYE) with an Outperform and a price target of $40. Fadem. All of these names earned a positive view based on the analysts Growth Opportunity and Concept Differentiation screens, with the last two also cited for their potential for near term improvement.
04/18/18
UBSW
04/18/18
NO CHANGE
Target $300
UBSW
Buy
O'Reilly Automotive demand stymied by weather, says UBS
UBS analyst Michael Lasser noted he is modeling a 2.5% decline in comps for O'Reilly Automotive, which is below consensus. He believes the early winter weather was supportive of auto parts sales but the coldest and snowiest March in years may have stymied the demand that sets in with the spring. Despite the weather, he still believes there were positive developments during the quarter. Lasser maintained his Buy rating and $300 price target on O'Reilly shares.
CMG Chipotle
$339.30

6.4 (1.92%)

04/23/18
JPMS
04/23/18
NO CHANGE
Target $320
JPMS
Neutral
Chipotle price target raised to $320 from $280 at JPMorgan
JPMorgan analyst John Ivankoe raised his price target for Chipotle Mexican Grill to $320 but keeps a Neutral rating on the name. Incoming interest on Chipotle has "taken a marked turn upwards" since the announcement that former Taco Bell CEO Brian Niccol would be taking over, Ivankoe tells investors in a research note. He believes, however, that investors shouldn't chase the shares following the recent rally. Competition and labor costs may make a substantive turnaround more difficult, the analyst contends. Ivankoe believes Chipotle shares are fairly priced.
04/18/18
RHCO
04/18/18
NO CHANGE
Target $380
RHCO
Buy
Chipotle price target raised to $380 from $340 at SunTrust
SunTrust analyst Jake Bartlett raised his price target on Chipotle to $380 as part of his broader research note previewing Q1 earnings for the restaurant group, where he says there is "further room" for stocks to run higher. While Bartlett does not anticipate an upside catalyst for Chipotle in Q1, he cites expectations of the "current sales initiatives, potential additional initiatives, easing year-ago comps and an improving consumer" trends driving strong SSS growth in the second half of 2018 and 2019. The analyst is also positive on Chipotle's digital order/pickup focus along with delivery options in their early stages driving the turnaround.
04/17/18
BARD
04/17/18
NO CHANGE
Target $400
BARD
Outperform
Chipotle fundamentals should improve in 2018, says Baird
Baird analyst David Tarantino anticipates Q1 comps for Chipotle to come in near estimates, but sees more downside risk relative to consensus, than upside potential. The analyst said investors will be listening to the new CEO's comments and his vision to fuel sustainable improvements in sales/profit momentum. He also expects signs of better fundamentals to emerge as 2018 unfolds. Tarantino reiterated his Outperform rating and $400 price target on Chipotle shares.
04/19/18
MAXM
04/19/18
NO CHANGE
Target $410
MAXM
Buy
Chipotle 'turnaround thesis remains intact', says Maxim
Maxim analyst Stephen Anderson kept his Buy rating and $410 price target on Chipotle ahead of its Q1 earnings next week. Although Anderson lowers his Q1 EPS view to $1.86 from $1.90 - which is still above consensus $1.60 - and also lowers his Q1 comps view to 1.2% from 1.5% due to the impact of bad weather, he still expects the company's turnaround to continue and continues to model FY18 SSS of 4.5%. The analyst adds that while Chipotle management has not emphasized stock buybacks, he expects repurchases to be a "significant" driver of earnings in FY18-FY19.
PCMI PCM, Inc.
$10.60

0.1 (0.95%)

04/28/17
ROTH
04/28/17
NO CHANGE
Target $34
ROTH
Buy
PCM, Inc. price target raised to $34 from $29 at Roth Capital
Roth Capital analyst William Gibson raised his price target for PCM, Inc. to $34 from $29 as momentum continues. The analyst reiterates a Buy rating on the shares.
11/07/17
ROTH
11/07/17
NO CHANGE
Target $18.5
ROTH
Buy
PCM, Inc. price target lowered to $18.50 from $28 at Roth Capital
Roth Capital analyst William Gibson lowered his price target for PCM, Inc. price target to $18.50 from $28 on valuation. The analyst reiterates a Buy rating on the shares.
AMD AMD
$9.72

-0.37 (-3.67%)

04/19/18
LEHM
04/19/18
NO CHANGE
Target $9
LEHM
Underweight
AMD price target lowered to $9 from $10 at Barclays
Barclays analyst Blayne Curtis lowered his price target for AMD (AMD) to $9 and keeps an Underweight rating on the name. Ahead of the company's Q1 results, the analyst says "mining drama is back to the forefront for GPUs." While restocking should help the June quarter, the risk to the second half will be the key debate, Curtis tells investors in a research note on U.S. Semiconductors. His best ideas for 2018 are Marvell Technology (MRVL), Intel (INTC) and Skyworks (SWKS).
04/05/18
04/05/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Merck (MRK) upgraded to Overweight from Equal Weight at Barclays with analyst Geoffrey Meacham saying he believes the company will continue to take share in first-line lung cancer, driven by positive KN-189 and KN-042 data. 2. Acuity Brands (AYI) upgraded to Outperform from Market Perform at JMP Securities with analyst Joseph Osha saying he believes the stock is finally trading at a "reasonable valuation based on reasonable expectations." 3. AMD (AMD) upgraded to Buy from Hold at Stifel with analyst Kevin Cassidy citing valuation and the company's margin expansion potential. 4. Tiffany (TIF) upgraded to Buy from Hold at Loop Capital with analyst Laura Champine saying her initial meeting with the company's new CEO Alessandro Bogliogo added to her confidence. 5. Citi (C) and Wells Fargo (WFC) were upgraded to Buy from Neutral at UBS. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/04/18
STFL
04/04/18
UPGRADE
Target $13
STFL
Buy
AMD upgraded to Buy from Hold at Stifel
Stifel analyst Kevin Cassidy upgraded AMD (AMD) to Buy from Hold with a $13 price target. The shares closed today up 22c, or 2.3%, to $9.77. The analyst cites valuation and the company's margin expansion potential for the upgrade. AMD is oversold on alternative crypto-currency mining solutions coming to market, Cassidy tells investors in a research note. He sees AMD's revenue ramping in the second half of 2018 due to sales of its EPYC processor. Cassidy coupled the upgrade with a downgrade of Intel (INTC) to Hold from Buy.
04/04/18
UBSW
04/04/18
INITIATION
Target $11
UBSW
Neutral
AMD initiated with a Neutral at UBS
UBS started AMD with a Neutral rating and $11 price target.
FB Facebook
$159.69

0.03 (0.02%)

04/20/18
FBCO
04/20/18
NO CHANGE
Target $230
FBCO
Outperform
Facebook price target lowered to $230 at Credit Suisse ahead of Q1 report
Credit Suisse analyst Stephen Ju lowered his price target on Facebook to $230 from $240 ahead of the company's Q1 earnings release on April 25. In a research note to investors, Ju, who has an Outperform rating on shares, said he "struggles for reasons as to why" his near-to-medium term estimates should materially change following advertiser conversations, which suggest little in the way of changes to budget allocations to Facebook, as well as OpEx and CapEx guidance parameters, which require the company to spend an incremental $15B. Stepping back from the recent controversy, Ju said he remains a buyer of Facebook shares and notes that his long-term thesis has not really changed.
04/23/18
WEDB
04/23/18
NO CHANGE
Target $260
WEDB
Outperform
Facebook Q1 results should be above consensus, says Wedbush
Wedbush analyst Michael Pachter expects Facebook's Q1 results above consensus estimates driven by continued audience and engagement growth, with an overall minimal impact from heightened scrutiny over privacy concerns. Notwithstanding heightened scrutiny and elevated legislative and regulatory risk, the analyst expects Facebook to weather the controversy surrounding its Cambridge Analytica data breach, and to continue to invest in various initiatives, with the majority, if not all, of those initiatives generating substantial EBITDA growth in years to come. Pachter reiterates an Outperform rating and $260 price target on the shares.
04/25/18
STFL
04/25/18
UPGRADE
Target $1234
STFL
Buy
Alphabet upgraded to Buy after post-earnings pullback at Stifel
As previously reported, Stifel analyst Scott Devitt upgraded Alphabet (GOOGL) to Buy from Hold, stating that he is increasingly comfortable with Alphabet's positioning in digital media relative to Facebook (FB)given Alphabet's private relationship with consumers and the high utility and durability of Google's core business. Also, he sees the reset of 2018's outlook following yesterday's earnings, and resulting pullback in shares, offering a reasonable buying level for shares. Devitt maintains his $1,234 price target on Alphabet.
04/20/18
BTIG
04/20/18
NO CHANGE
Target $46
BTIG
Buy
WWE price target raised to $46 from $36 at BTIG
BTIG analyst Brandon Ross raised his price target on WWE (WWE) to $46, citing the company's confidence that they can come to an agreement on renewing the rights to their Raw and SmackDown programs which are set to expire in Q3 of 2019. The analyst adds that he has turned "more bullish" regarding the outcome of these negotiations over the past several weeks, suggesting the demand for live programming could lead to emergence of interested bidders among digital platforms such as Facebook (FB).
ECHO Echo Global
$27.80

0.15 (0.54%)

02/08/18
BRRR
02/08/18
NO CHANGE
Target $35
BRRR
Outperform
Echo Global price target raised to $35 after earnings at Barrington
Barrington analyst Kevin Steinke believes the truckload market reach an inflection point starting in Q3 that will lead to continuing solid demand for Echo Global throughout 2018. Given the company's solid outlook and the favorable market environment, Steinke raised his price target to $35 from $26 on Echo Global shares and keeps an Outperform rating on the stock.
02/23/18
MSCO
02/23/18
DOWNGRADE
MSCO
Underweight
Echo Global downgraded to Underweight from Equal Weight at Morgan Stanley
02/23/18
02/23/18
DOWNGRADE
Target $20

Underweight
Echo Global downgraded to Underweight at Morgan Stanley
As previously reported, Morgan Stanley analyst Ravi Shanker downgraded Echo Global to Underweight from Equal Weight, as he believes brokers like Echo deserve a "mid-teens multiple at best" as he thinks the mandate for electronic logging devices, or ELDs, will present a challenge to all brokers. Though Echo's high spot exposure may leave it somewhat better positioned than contract exposed peers, Shanker sees this as more than priced into the stock, he tells investors, adding that the market appears to be significantly underestimating the risk of shippers reducing their reliance on brokers altogether in 2018. Due largely to a 20% EPS increase from tax reform, Shanker increased his price target on Echo shares to $20 from $15.
02/23/18
02/23/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. UPS (UPS) downgraded to Hold from Buy at Deutsche Bank with analyst Amit Mehrotra saying UPS's capex guidance was worse than even the most bearish expectations. 2. Echo Global (ECHO) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Ravi Shanker saying he believes brokers like Echo deserve a "mid-teens multiple at best" as he thinks the mandate for electronic logging devices, or ELDs, will present a challenge to all brokers. 3. Ardagh Group (ARD) downgraded to Market Perform from Outperform at Wells Fargo with analyst Christopher Manuel saying he analyst now sees "limited capital redeployment options" for Ardagh over the next 24-36 months. 4. Acacia Communications (ACIA) downgraded to Neutral from Buy at MKM Partners and to Hold from Buy at DA Davidson and Needham. 5. Aegean Marine (ANW) downgraded to Hold from Buy at Stifel with analyst Benjamin Nolan saying the company's deal to buy the parent company of Hellenic Environmental Centers "takes the cake" in terms of questionable deals, adding "it is hard to even fathom how any transaction could possibly be worse." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
XLNX Xilinx
$63.70

-0.34 (-0.53%)

04/06/18
04/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Incyte (INCY) downgraded to Neutral from Buy at Guggenheim and to Market Perform from Outperform at William Blair. 2. Ormat Technologies (ORA) downgraded to Perform from Outperform at Oppenheimer with analyst Noah Kaye citing valuation. 3. Sprague Resources (SRLP) downgraded to Underweight from Neutral at JPMorgan with analyst Andrew Burd citing the stock's year-to-date outperformance for the downgrade. 4. Banc of California (BANC) downgraded to Underperform from Neutral at BofA/Merrill with analyst Ebrahim Poonwala saying the company's new management team is working towards achieving its long-term strategic targets but is cautious on elevated execution risk given the balance sheet overhaul and lower quality deposit base. 5. Xilinx (XLNX) downgraded to Underweight from Neutral at JPMorgan with analyst Harlan Sur saying he believes multiple compression is likely with basestation deployment in China likely to decline in 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/13/18
KEYB
03/13/18
NO CHANGE
KEYB
Broadcom could look at Micron next with Qualcomm blocked, says KeyBanc
President Trump's order to block Broadcom's (AVGO) proposed takeover of Qualcomm (QCOM) also likely blocks the possibility of the company trying to acquire any other player with any military/defense exposure, such as Xilinx (XLNX), KeyBanc analyst John Vinh tells investors. However, he expects Broadcom to remain acquisitive and thinks Micron (MU) could be another potential target, citing a lack of security concerns and Broadcom's previous attempts to bid for Toshiba (TOSBF), he noted. Vinh reiterates his Overweight rating and $320 price target on Broadcom, adding that he sees the executive order as a "slight positive," since it removes a near-term distraction and overhang.
04/06/18
JPMS
04/06/18
DOWNGRADE
Target $68
JPMS
Underweight
Xilinx downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Harlan Sur downgraded Xilinx to Underweight and cut his price target for the shares to $68 from $73. The analyst believes multiple compression is likely with basestation deployment in China likely to decline in 2018. Further, the analyst believes expectations for 5G are high.
04/13/18
SBSH
04/13/18
INITIATION
Target $300
SBSH
Buy
Citi assumes Broadcom at Buy, says Xilinx possible next target
Citi analyst Christopher Danely resumed coverage of Broadcom (AVGO) with a Buy rating and $300 price target citing strength in the core business and accretion from acquisitions. The analyst believes Broadcom can grow its revenue at 8% annually over the next two years, above the average historical semiconductor industry growth of 5%. He estimates the most recent acquisition of Brocade is roughly $1.32, or 8%, accretive to Broadcom's combined 2019 earnings per share of $18.43. Danely believes Xilinx (XLNX) could be Broadcom's next acquisition target. He sees the deal being $1.06, or 6% accretive to earnings per share.
PYPL PayPal
$74.00

-1.29 (-1.71%)

04/18/18
MSCO
04/18/18
UPGRADE
Target $58
MSCO
Overweight
eBay upgraded to Overweight from Underweight at Morgan Stanley
Morgan Stanley analyst Brian Nowak upgraded eBay (EBAY) two notches, to Overweight from Underweight, as expects the company to start pulling away from PayPal (PYPL) and intermediating its own payments in 2018, with a planned full transition in mid-2020. He is bullish about this initiative, noting that other leading platforms - including Amazon (AMZN), Booking (BKNG), and others - have seen higher user conversion and spending from more integrated and comprehensive payment offerings, Nowak tells investors. Not only can payments drive faster GMV growth, it can also add 20% to companywide EBIT, Nowak estimates. He raised his price target on eBay shares to $58 from $36.
04/18/18
NOMU
04/18/18
NO CHANGE
Target $65
NOMU
Buy
Nomura Instinet ups Square price target to $65 on bitcoin boost
Nomura Instinet analyst Dan Dolev raised his price target for Square (SQ) shares to $65 from $64 saying the impact from bitcoin could be meaningful. The stock closed yesterday up $2.10 to $49.13. Opening Square Cash for bitcoin trading earlier this year could drive a "sizable boost" to revenue and profits, driving up to 10% potential upside to adjusted EBITDA guidance, Dolev tells investors in a research note. He sees bitcoin as helping to offset Square's rising investment costs to broaden its international presence. In asking if bitcoin will reshape the future of payments as Square CEO Jack Dorsey often argues, or if it will just be a passing fad, Dolev points out that the company's correlation with the cryptocurrency has been on a downward trend. Square shares are now less correlated with bitcoin than PayPal (PYPL), the payment networks or Alphabet (GOOG, GOOGL), Dolev contends. He maintains a Buy rating on Square.
04/11/18
LOOP
04/11/18
NO CHANGE
Target $70
LOOP
Hold
PayPal extension to banking services may add value, says Loop Capital
Loop Capital analyst Joseph Vafi writes that yesterday's suggestion by PayPal (PYPL) COO to direct more of the company's focus toward "bank-like services," including debit cards and check deposits, would be a positive strategic direction given the "underbanked" conditions, growth, and margin expansion potential of that market. Vafi adds that these services could also provide a brand expansion for Venmo and "stem transaction margin declines" in PayPal's core business. The analyst keeps his Hold rating and $70 price target however, stating that PayPal valuation is "essentially at parity" with the main card networks Visa (V) and MasterCard (MA).
04/20/18
JEFF
04/20/18
NO CHANGE
Target $98
JEFF
Buy
PayPal impact from eBay still looks manageable, says Jefferies
Jefferies analyst Ramsey El-Assal says his updated analysis reinforces his prior view that the impact from losing exclusivity at eBay (EBAY) should prove "quite manageable" for PayPal (PYPL). The most likely outcome is a low-single-digit revenue decline and a mid- to high-single-digit earnings decline in 2020 for PayPal, El-Assal tells investors in a research note. He notes that this does not take into consideration any offsetting acquisitions or buybacks utilizing PayPal's "sizable unlevered" cash holdings. In addition, the analyst believes the company's fundamentals in Q1 look solid. He keeps a Buy rating on the shares with a $98 price target.
ALGN Align Technology
$245.24

5.72 (2.39%)

04/18/18
MSCO
04/18/18
DOWNGRADE
MSCO
Equal Weight
Align Technology downgraded to Equal Weight from Overweight at Morgan Stanley
04/19/18
04/19/18
DOWNGRADE
Target $270

Equal Weight
Align Technology downgraded on signs of slowing growth at Morgan Stanley
As previously reported, Morgan Stanley analyst Steve Beuchaw downgraded Align Technology to Equal Weight from Overweight, stating that his web trends tracking implies growth in the next 1-2 quarters slows to 25% from 35%. When growth was last at that level, the stock's multiple was 30% lower compared to the S&P, noted Beuchaw, who called Align's current elevated multiple "demanding." He lowered his price target on Align Technology shares to $270 from $300.
04/19/18
04/19/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Clorox (CLX) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Dara Mohsenian saying valuation looks "stretched" on muted earnings growth and lowered his fiscal 2019 earnings estimate by 2% to reflect deterioration in U.S. Household Products sector. 2. Adtran (ADTN) downgraded to Hold from Buy at Argus with analyst Jim Kelleher saying the company has pushed out its expectations for a key client conducting a strategic review of spending, leading to revenue decline for its North America segment to an all-time low. 3. Align Technology (ALGN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Steve Beuchaw saying his web trends tracking implies growth in the next 1-2 quarters slows to 25% from 35%. 4. ConocoPhillips (COP) downgraded to Hold from Buy at Edward Jones with analyst Jason Gammel citing valuation following the recent rally in the shares. 5. Valvoline (VVV) downgraded to Neutral from Buy at Longbow with analyst Dmitry Silversteyn saying he sees a slower pace of price realization in Quick Lubes combined with a higher cost outlook, limiting earnings upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/20/18
BREN
04/20/18
INITIATION
Target $305
BREN
Buy
Align Technology initiated with a Buy at Berenberg
Berenberg initiated Align Technology with a Buy and $305 price target.
CTXS Citrix
$96.54

0.04 (0.04%)

01/11/18
COWN
01/11/18
DOWNGRADE
Target $93
COWN
Market Perform
Citrix downgraded to Market Perform at Cowen
As reported previously, Cowen analyst Gregg Moskowitz downgraded Citrix to Market Perform from Outperform. The analyst said he remains positive on the company's cloud transition but he believes the share price represents fair value. Moskowitz raised his price target to $93 from $90 on Citrix shares.
04/18/18
BARD
04/18/18
NO CHANGE
Target $110
BARD
Outperform
Citrix price target raised to $110 from $100 at Baird
Baird analyst Rob Oliver raised his price target on Citrix to $110 from $100 ahead of Q1 results. The analyst noted investors expectations are elevated, but his recent channel survey showed the largest tier of partners indicated the most positive responses on the survey. He likes the risk/reward at current levels and expects Q1 to be at least in-line. Oliver reiterated his Outperform rating on Citrix shares.
02/01/18
BERN
02/01/18
NO CHANGE
Target $106
BERN
Outperform
Citrix price target raised to $106 from $95 at Bernstein
Bernstein analyst Mark Moerdler raised his price target for Citrix to $106 from $95, citing return of capital and cost control amid the Cloud transition. The analyst reiterates an Outperform rating on the shares.
04/20/18
SBSH
04/20/18
NO CHANGE
Target $120
SBSH
Buy
Citi sees 'multiple catalysts' for Citrix, ups price target to $120
Citi analyst Walter Pritchard raised his price target for Citrix Systems to $120 from $94 citing increased conviction in the stock post his analysis on subscription transition and drivers of top-line and profitability growth. The analyst sees upside to Street numbers and management targets. Citrix continues to operate in a "strong cost discipline environment," which creates room for continued growth in year-over-year operating margins, Pritchard tells investors in a research note. The analyst sees "multiple catalysts ahead" and keeps a Buy rating on the shares.
V Visa
$121.00

-0.41 (-0.34%)

04/17/18
JEFF
04/17/18
NO CHANGE
Target $200
JEFF
Buy
Jefferies boosts price targets on Mastercard, Visa ahead of Q1 results
Jefferies analyst Ramsey El-Assal raised his price target for Mastercard (MA) to $200 from $195 and for Visa (V) to $145 from $143 ahead of the Q1 earnings reports. The analyst's analysis of leading indicators points to a "healthy fundamental backdrop" for both companies in the quarter. He raised his estimates above consensus and maintains a "modest relative preference" for Mastercard citing a more favorable growth profile. El-Assal keeps Buy rating on both stocks.
03/27/18
BERN
03/27/18
INITIATION
Target $143
BERN
Outperform
Visa initiated with an Outperform at Bernstein
Bernstein started Visa with an Outperform rating and $143 price target.
02/05/18
BMOC
02/05/18
NO CHANGE
Target $148
BMOC
Outperform
Visa price target raised to $148 from $134 at BMO Capital
BMO Capital analyst Paulo Ribeiro raised his price target on Visa to $148, saying he is positive on the company's second-half of 2018 amid " strong underlying global payment trends and fundamentals". Ribeiro says investors were disappointed that the company maintained its FY18 outlook, but notes that the management chose to be cautious ahead of the "challenging" Q2. The analyst keeps his Outperform rating on Visa, forecasting potential second-half upside from "pricing, Incentives easing and lapping of tough comps".
CLGX CoreLogic
$43.85

-0.57 (-1.28%)

02/06/18
02/06/18
DOWNGRADE

Sell
CoreLogic downgraded to Sell at Compass Point
As previously reported, Compass Point downgraded CoreLogic to Sell from Neutral and cut its price target to $43 from $49. Analyst Chris Gamaitoni said CoreLogic is the most sensitive to declining volume in as mortgage insurance and mortgage technology coverage. Further, with consumer confidence flat year-over-year and interest rates rising, Gamaitoni estimates the company cold miss 2019 estimates by 11.4%, making risk/reward "poor."
02/27/18
DBAB
02/27/18
NO CHANGE
Target $33
DBAB
Sell
CoreLogic 2018 outlook supports discounted multiple, says Deutsche Bank
Deutsche Bank analyst Kevin McVeigh believes CoreLogic's 2018 outlook supports a discounted valuation multiple. VSG will continue to underwhelm as large clients continue to diversify, more than offsetting new wins, McVeigh tells investors in a post-earnings research note. He believes "underwhelming fundamentals and challenging margin targets" warrant a more compressed multiple for the shares. The analyst keeps a Sell rating on CoreLogic with a $33 price target.
01/03/18
COMP
01/03/18
INITIATION
Target $49
COMP
Neutral
CoreLogic initiated with a Neutral at Compass Point
Compass Point initiated CoreLogic with a Neutral and a $52 price target.
02/06/18
COMP
02/06/18
DOWNGRADE
COMP
Sell
CoreLogic downgraded to Sell from Neutral at Compass Point
F Ford
$11.11

0.16 (1.46%)

04/09/18
04/09/18
UPGRADE
Target $48

Overweight
GM upgraded to Overweight on infrastructure bill potential at Morgan Stanley
As previously reported, Morgan Stanley analyst Adam Jonas upgraded General Motors (GM) to Overweight from Equal Weight, as he sees room for positive earnings revisions for GM, Ford (F) and Fiat Chrysler (FCAU) as investors better understand the impact on U.S. pick-up truck sales from a potential passage of a U.S. infrastructure bill. The firm's economics team estimates a bull case of as much as $2.4T in U.S. infrastructure spending over a 10-year period, which primarily would affect automakers through the sale of highly-profitable pickup trucks, said Jonas, who noted that greater infrastructure spending typically does coincide with increased pickup sales. Jonas raised his price target on GM shares to $48 from $45 and increased his price target on Fiat Chrysler to EUR23 from EUR22 per share.
03/26/18
DBAB
03/26/18
NO CHANGE
DBAB
Hold
Deutsche sees no 'easy fix' for Ford, but likes near-term risk/reward
After spending a few weeks examining Ford's competitive position, Deutsche Bank analyst Rod Lache says the company's "predicament does not lend itself to an easy fix." A large proportion of Ford's portfolio resides in mass market segments that are structurally challenged, Lache tells investors in a research note. He believes a "durable organic turnaround would be costly and take several years to achieve." The analyst, however, believes Ford will show progress in North America over the near-to-intermediate term. Further, Ford may surprise the market in articulating a plan that does not jeopardize current dividend levels, Lache adds. He likes the stock's near-term risk/reward profile with "catalysts on the horizon" but keeps a Hold rating on the name.
03/14/18
03/14/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ford (F) double upgraded to Overweight from Underweight, with analyst Adam Jonas saying sentiment on Ford has reached a cyclical low and this has taken valuation to attractive levels, estimating that the F-150 franchise alone may be worth more than 150% of the company's total current enterprise value. 2. Sabra Health Care (SBRA) upgraded to Buy from Neutral at Mizuho with analyst Richard Anderson citing "deeply" discounted valuation and a possible near-term catalyst from its Genesis sales. 3. Oceaneering (OII) upgraded to Hold from Underperform at Jefferies with analyst Eduardo Royes saying he no longer sees ample downside to medium-term estimates. 4. RH (RH) upgraded to Outperform from Market Perform at Raymond James with analyst Budd Bugatch saying he believes the company's "sizable" business transformation is behind it and the share decline year-to-date provides attractive risk/reward. 5. BHP Billiton (BHP) upgraded to Neutral from Sell at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/18
MSCO
04/17/18
NO CHANGE
Target $15
MSCO
Overweight
Ford unlikely to make restructuring announcement yet, says Morgan Stanley
Morgan Stanley analyst Adam Jonas said that while he sees significant room for Ford to restructure its operations, he also believes it is likely too soon for management to communicate a detailed restructuring plan. If he is correct, disappointment that no restructuring plan comes along with the company's Q1 report on April 25 could create a buying opportunity, said Jonas, who maintains an Overweight rating on Ford given its restructuring and strategic repositioning potential as well as its exposure to upside from U.S. infrastructure spending.
QCOM Qualcomm
$49.77

-0.17 (-0.34%)

04/24/18
RBCM
04/24/18
NO CHANGE
Target $75
RBCM
Outperform
Qualcomm price target lowered to $75 from $80 at RBC Capital
RBC Capital analyst Amit Daryanani lowered his price target on Qualcomm (QCOM) to $75 ahead of the company's earnings tomorrow, citing his supply chain conversations suggesting a "muted" iPhone (AAPL) and Samsung (SSNLF) GS9 unit shipment growth along with lackluster smartphone demand in China. Longer term, the analyst keeps his Outperform rating on Qualcomm with a view toward potential catalysts being "licensing resolution", the close of NXP Semiconductors (NXPI) deal or a "material buyback, and cost reductions.
04/17/18
MSCO
04/17/18
NO CHANGE
Target $55
MSCO
Underweight
Qualcomm faces headwinds even if NXP deal gets approved, says Morgan Stanley
Morgan Stanley analyst James Faucette believes the market has built in a meaningful probability that China blocks Qualcomm's (QCOM) acquisition of NXP Semiconductors (NXPI), though he feels it is in China's best interest to approve the deal and he feels that is what will happen. However, even if the NXP deal gets approved, he continues to think the Apple (AAPL) lawsuit is unlikely to conclude before FY19 and he sees its as increasingly likely that licensing disputes with other non-paying OEM will be a persistent issue. Share gains made by MediaTek and the ZTE (ZTCOY) ban could create added EPS headwinds for Qualcomm, said Faucette, who maintains an Underweight rating on the stock.
04/23/18
DBAB
04/23/18
NO CHANGE
DBAB
Hold
NXP could be worth 5%-10% more if deal breaks, says Deutsche Bank
Deutsche Bank analyst Ross Seymore continues to have a successful Qualcomm (QCOM) acquisition close as his base case for NXP Semiconductors (NXPI), but he agrees with investors that risks of a break are rising. In a break scenario, the analyst sees 5%-10% upside to NXP shares on a normalized basis. However, before that normalized level is attained, Seymore sees 10% downside risk as the current "arb-laden shareholder base would likely exhibit significant turnover." Consequently, while the long-term risk/reward is becoming intriguing, near-term event/political uncertainty is likely to remain elevated, the analyst tells investors in a research note. As such, he keeps a Hold rating on NXP.
04/20/18
ADAM
04/20/18
NO CHANGE
Target $79
ADAM
Buy
Qualcomm price target lowered to $79 from $86 at Canaccord
Canaccord analyst T. Michael Walkley lowered his price target on Qualcomm (QCOM) to $79 from $86. The analyst said the recent selloff was likely due to trade war issues with China, but he also believes investors are now pricing in a lower probability it will receive approval for its acquisition of NXP Semiconductor (NXPI). He also lowered his near-term estimates on Qualcomm due to sluggish smartphone trends. Walkley maintained his Buy rating on Qualcomm shares.
LVS Las Vegas Sands
$72.42

-1.38 (-1.87%)

03/15/18
MSCO
03/15/18
NO CHANGE
MSCO
Las Vegas Sands, Wynn Resorts targets raised at Morgan Stanley after Macau trip
After visiting Macau last week, Morgan Stanley analyst Thomas Allen raised his 2018/2019 EBITDA forecast for Las Vegas Sands by 1%, citing strong visitation growth over Chinese New Year, less MGM (MGM) Cotai cannibalization, and less renovation disruption at Cotai Central, all of which make him lower his projection for Las Vegas' market share decline to only 0.4% in loss versus his prior view of a 1% share loss. While it appears the new MGM Cotai has attracted a lot of visitors since opening, Allen believes a mixture of service issues and low hold will impact near-term results. For Wynn Resorts (WYNN), Allen raised his 2018/2019 EBITDA view by 4%/2% to reflect stronger results in both Macau and Vegas. Allen increased his price target on Las Vegas Sands shares to $82 from $81, upped his Wynn target to $194 from $193 and keeps a $40 price target on MGM Resorts.
03/13/18
TLSY
03/13/18
INITIATION
TLSY
Market Perform
Las Vegas Sands initiated with a Market Perform at Telsey Advisory
03/08/18
STFL
03/08/18
NO CHANGE
STFL
Stifel returns from Macau trip with 'much more positive' view for 2018
Stifel analyst Steven Wieczynski said that after meeting with property managements and industry contacts in Macau recently he came back with a "much more positive/constructive view for 2018" than he was previously forecasting. It was clear that operators were "thrilled" with how the Chinese New Year holiday played out and demand post-CNY had continued to be strong, especially on the VIP side, Wieczynski tells investors. He maintains his Buy rating on Las Vegas Sands (LVS) and Hold ratings on MGM Resorts (MGM) and Wynn Resorts (WYNN). Melco Resorts (MLCO) is another publicly traded company in the Macau gaming space.
04/19/18
MSCO
04/19/18
NO CHANGE
Target $84
MSCO
Overweight
Las Vegas Sands called top pick on Macau market shift at Morgan Stanley
Morgan Stanley analyst Thomas Allen called Las Vegas Sands his top pick, as he thinks investors have yet to appreciate the shift in momentum from VIP to mass market in Macau. Sands' positioning in mass market in Macau "looks as strong as it's ever been," with 30% mass share compared to 7-19% for the other 5 concessionaires, Allen tells investors. He fells the consensus view for meaningful Macau share loss for Sands in 2018 is too pessimistic. Allen maintains an Overweight rating on Las Vegas Sands and raised his price target on the stock to $84 from $83.
LM Legg Mason
$37.64

0.25 (0.67%)

01/03/18
01/03/18
DOWNGRADE
Target $49

Neutral
Legg Mason downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Craig Siegenthaler downgraded Legg Mason to Neutral from Outperform, with a $49 price target, following the U.S. corporate tax reform and Q4 marks.
01/10/18
JEFF
01/10/18
DOWNGRADE
Target $45
JEFF
Hold
Legg Mason downgraded to Hold from Buy at Jefferies
Jefferies analyst Daniel Fannon downgraded Legg Mason to Hold and cut his price target for the shares to $45 from $48. The stock is up near 35% over the last 12 months and are now trading in line with peers, Fannon tells investors in a research note. The analyst sees an "increasingly balanced risk/reward profile" amid deteriorating equity performance at ClearBridge and a "more volatile" flow environment.
01/03/18
FBCO
01/03/18
DOWNGRADE
FBCO
Neutral
Legg Mason downgraded to Neutral from Outperform at Credit Suisse
01/25/18
RBCM
01/25/18
NO CHANGE
Target $57
RBCM
Outperform
Legg Mason price target raised to $57 from $49 at RBC Capital
RBC Capital analyst Kenneth Lee raised his price target on Legg Mason to $57 and kept his Outperform rating after a Q3 earnings beat. Lee says the results were helped by "higher than expected non-pass-through performance fees and benefit from operating leverage", adding the strong fixed income flows were also positive. The analyst notes that Legg Mason can drive organic growth amid changing industry trends thanks to its well-diversified platform.
INTU Intuit
$176.38

-2.25 (-1.26%)

02/26/18
ARGS
02/26/18
NO CHANGE
Target $195
ARGS
Buy
Intuit price target raised to $195 from $175 at Argus
Argus analyst Jim Kelleher raised his price target on Intuit to $195 after the company's Q2 earnings beat, adding that despite the strong run-up in the stock price over the past two years, valuation remains attractive. Longer term, Kelleher keeps his Buy rating based on the "rise of the entrepreneurial economy and the demise of the 'job-for-life' mentality", which should drive growth in accounting and tax needs for small businesses and self-employed.
01/29/18
OPCO
01/29/18
NO CHANGE
Target $181
OPCO
Outperform
Intuit price target raised to $181 from $166 at Oppenheimer
Oppenheimer analyst Scott Schneeberger raised his price target for Intuit to $181 from $166 to reflect the anticipated impact from tax reform on tax rates per the company's updated guidance. The analyst reiterates an Outperform rating on the shares.
02/12/18
DBAB
02/12/18
NO CHANGE
Target $190
DBAB
Buy
Intuit price target raised to $190 from $180 at Deutsche Bank
Deutsche Bank analyst Nandan Amladi raised his price target for Intuit to $190 saying the company is his to pick in Global Cloud Accounting Software. Intuit has "effectively tapped into the unserved self-employed segment," Amladi tells investors in a research note. His analysis indicates QBO unit growth rates recently accelerated above 50%. The analyst keeps a Buy rating on the shares.
03/12/18
FBCO
03/12/18
NO CHANGE
Target $195
FBCO
Outperform
H&R Block's DIY e-filings growth bodes well for Intuit, Credit Suisse says
Credit Suisse analyst Michael Nemeroff raised his price target on Intuit (INTU) to $195 from $185 and maintained an Outperform rating. In a research note to investors, the analyst said recent results at H&R Block (HRB) indicating "strong" growth in do-it-yourself e-filings bode well for "DIY leader" Intuit. H&R Block said DIY e-filings were up 6.2% year over year through February 23rd vs. IRS growth of 2.4% int he same period, suggesting that H&R Block is performing well this year in DIY, which he views as a positive read-across for Intuit. He also noted that while H&R Block's 6.2% DIY growth appears impressive, "it's growing off a much smaller base" than Intuit.
TWTR Twitter
$29.88

-0.6 (-1.97%)

04/25/18
UBSW
04/25/18
UPGRADE
Target $36
UBSW
Buy
UBS upgrades Twitter to Buy, boosts price target to $36
UBS analyst Eric Sheridan right before the market closed upgraded his rating on Twitter to Buy from Neutral and boosted his price target for the shares to $36 from $32. The stock closed the day down 72c to $29.75. This morning's Q1 results show Twiter's user and engagement growth has improved and, as a result, advertisers are returning to capture improving return on investments, Sheridan tells investors in a research note. Further, the analyst believes "forward momentum on revenue growth" should allow Twitter to see increased operating leverage, "well ahead" of current Street forecasts. He thinks investors should look past the short-term and examine forward trends for Twitter, which he calls "more constructive."
04/25/18
UBSW
04/25/18
UPGRADE
UBSW
Buy
Twitter upgraded to Buy from Neutral at UBS
04/25/18
04/25/18
UPGRADE

Market Perform
Twitter upgraded to Market Perform at Raymond James
As previously reported, Raymond James analyst Aaron Kessler upgraded Twitter to Market Perform from Underperform given improving advertising growth rates driven by improved sales execution, improved ROI for advertisers, mix shift to video, and strong international growth. Additionally, his recent checks indicate more positive advertiser/agency sentiment toward Twitter. Furthermore, the analyst argues that valuation is reasonable given improved growth outlook and margin leverage.
04/25/18
RAJA
04/25/18
UPGRADE
RAJA
Market Perform
Twitter upgraded to Market Perform from Underperform at Raymond James
FARO FARO Technologies
$60.50

-1.85 (-2.97%)

11/27/17
CHLM
11/27/17
NO CHANGE
Target $60
CHLM
Buy
FARO Technologies price target raised to $60 from $55 at Craig-Hallum
Craig-Hallum analyst Greg Palm raised his price target for FARO Technologies to $60 from $55 as he is incrementally more confident in the near-term trajectory and potential for additional positive earnings surprises following a significant multi-year turnaround after traveling with the company's CFO Bob Seidel. The analyst sees further share price appreciation on continued evidence of the recent turnaround and management's ability to hit its 2019 targets. He reiterates a Buy rating on the shares.
02/23/18
NEED
02/23/18
NO CHANGE
Target $65
NEED
Buy
FARO Technologies price target raised to $65 from $53 at Needham
Needham analyst James Ricchiuti raised his price target on FARO Technologies to $65 after the company's Q4 earnings beat, saying the company saw the strongest operating margins in the quarter in 3 years. Ricchiuti adds that FARO Technologies has entered 2018 with strong momentum in the construction BIM/CIM market and expects the management to reposition the company in new growth markets over the next two years.
02/23/18
CHLM
02/23/18
NO CHANGE
Target $68
CHLM
Buy
FARO Technologies price target raised to $68 from $60 at Craig-Hallum
Craig-Hallum analyst Greg Palm raised his price target on FARO Technologies to $68 from $60 and reiterated a Buy rating after the company "handily" beat expectations for the second quarter in a row. In a research note to investors, Palm said he expects increased investor interest following back-to-back "solid" quarters and says estimates remain well below management's fiscal 2019 targets, leaving plenty of room for upward earnings revisions should solid execution continue.
02/23/18
ADAM
02/23/18
NO CHANGE
Target $66
ADAM
Buy
FARO Technologies price target raised to $66 from $52 at Canaccord
Canaccord analyst Bobby Burleson raised his price target on FARO Technologies to $66 from $52, saying the company appears well positioned to deliver operating leverage as revenue growth rates recover into the mid-teens. He also sees new products and investments in emerging verticals driving more sustainable growth going forward. Burleson reiterated his Buy rating on FARO shares.
LMAT LeMaitre
$39.00

0.19 (0.49%)

10/27/17
10/27/17
DOWNGRADE

Hold
LeMaitre downgraded to Hold on slowing growth at Benchmark
As previously reported, Benchmark analyst Raymond Myers downgraded LeMaitre (LMAT) to Hold from Buy noting that is growth has slowed from its prior "unsustainable" pace and he sees some operational challenges. In the wake of the "unexpected" mid-2016 support from Baxter's (BAX) competitive recall, he anticipates tougher 2017 comparisons, he tells investors.
10/27/17
FANA
10/27/17
DOWNGRADE
FANA
Equal-Weight
LeMaitre downgraded to Equal-Weight from Overweight at First Analysis
First Analysis analyst Joseph Munda downgraded LeMaitre Vascular to Equal-Weight citing valuation following the company's Q3 results. The analyst believes the company's fundamentals remain attractive and keeps a $34 price target for the shares.
02/22/18
BRRR
02/22/18
NO CHANGE
BRRR
LeMaitre earnings, guidance solid, says Barrington
Barrington analyst Michael Petusky maintained a Market Perform rating on LeMaitre shares, saying while the company reported a solid Q4, exceeding the firm's estimate on the bottom line, increased its dividend 27.3%, and guided for a solid FY18, it remains difficult to gauge valuation, and Petusky would reconsider if the event of non-fundamental share weakness.
10/27/17
BNCH
10/27/17
DOWNGRADE
BNCH
Hold
LeMaitre downgraded to Hold from Buy at Benchmark
UHS Universal Health
$122.03

1.5 (1.24%)

01/30/18
WELS
01/30/18
INITIATION
Target $144
WELS
Outperform
Universal Health resumed with an Outperform at Wells Fargo
Wells Fargo analyst Peter Costa resumed coverage of Universal Health Services with an Outperform rating and $144 price target. The company's "consistency and management skills" should allow it to trade at premium, the analyst contends.
03/05/18
FBCO
03/05/18
NO CHANGE
Target $140
FBCO
Outperform
Universal Health price target raised to $140 from $135 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for Universal Health to $140 from $135 on valuation. The analyst reiterates an Outperform rating on the shares.
03/06/18
BARD
03/06/18
NO CHANGE
Target $140
BARD
Outperform
Universal Health price target raised to $140 from $122 at Baird
Baird analyst Whit Mayo raised his price target on Universal Health to $140 from $122 following good Q4 results. The analyst said the results were underpinned by incredibly strong acute growth and improved health plan trends. He noted improved guidance and a clear inflection with the behavioral health side. Mayo reiterated his Outperform rating on Universal Health shares.
01/03/18
GSCO
01/03/18
INITIATION
Target $137
GSCO
Buy
Universal Health initiated with a Buy at Goldman Sachs
Goldman analyst Stephen Tanal initiated Universal Health with a Buy and $137 price target given its unique positioning with strong behavioral health assets and strong balance sheet.
EBAY eBay
$40.98

-0.2 (-0.49%)

04/20/18
FBCO
04/20/18
NO CHANGE
Target $60
FBCO
Outperform
eBay price target raised to $60 at Credit Suisse ahead of Q1 earnings
Credit Suisse analyst Stephen Ju raised his price target on eBay to $60 from $51 ahead of its Q1 earnings report on April 25. In a research note to investors called "At the beginning of a new shareholder value creation cycle," Ju maintained his Outperform rating and noted that GMV acceleration has been an "undeniable positive" for eBay, but take rate improvements ultimately exert a greater impact on revenue and free cash flow.
04/19/18
SBSH
04/19/18
NO CHANGE
Target $58
SBSH
Buy
Citi boosts eBay target to $58, raises to second top pick in Internet
eBay (EBAY) shares do not reflect the value of the recently announced new payment solution, Citi analyst Mark May tells investors in a research note. He estimates the solution will increase earnings by 20% in its first full-year and has a net present value of $8 per share. May raised his price target for eBay to $58 and $50 and elevated the stock four spots to become his second to pick in Internet, behind only Amazon.com (AMZN). He views eBay's valuation as attractive and keeps a Buy rating on the shares.
04/18/18
04/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. eBay (EBAY) upgraded to Overweight from Underweight at Morgan Stanley with analyst Brian Nowak saying he expects the company to start pulling away from PayPal (PYPL) and intermediating its own payments in 2018, with a planned full transition in mid-2020. 2. First Solar (FSLR) upgraded to Buy from Neutral at BofA/Merrill with analyst Julien Dumoulin-Smith saying recent data is increasingly positive with unabated year-over-year Chinese solar demand, domestic safe harbor datapoints firming with a potential release in a couple months, firming domestic pricing, less likely import tariff exemptions, and a constructive cost trajectory for Series 65. 3. Dollar Tree (DLTR) upgraded to Buy from Hold at Loop Capital with analyst Anthony Chukumba saying while Dollar Tree's fiscal 2018 earnings guidance came up short of consensus expectations, management is correctly prioritizing long-term competitiveness over higher short-term profitability. 4. M&T Bank (MTB) upgraded to Neutral from Underperform at Baird with analyst David George citing its recent pullback as the shares have been hit hard and his belief this high quality bank should retain its premium valuation. 5. Pinnacle Financial (PNFP) upgraded to Outperform from Market Perform at Hovde Group and Fig Partners. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
T AT&T
$35.19

0.19 (0.54%)

04/17/18
PIVT
04/17/18
DOWNGRADE
Target $105
PIVT
Hold
Time Warner downgraded to Hold from Buy at Pivotal Research
Pivotal Research analyst Brian Wieser downgraded Time Warner (TWX) to Hold and lowered his price target for the shares to $105 from $108. The stock's value is driven by current trading levels of AT&T (T) under a presumption that the sale of the company goes through, Wieser tells investors in a research note.
04/12/18
NOMU
04/12/18
NO CHANGE
Target $48
NOMU
Buy
CommScope price target raised to $48 from $42 at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal raised his price target for CommScope (COMM) to $48 saying "rapidly increasing" AT&T (T) FirstNet spending will lift the company's 2018 revenues "easily above consensus expectations." FirstNet represents a "rare inflection in a typically methodical story," Kvaal tells investors in a research note. He keeps a Buy rating on CommScope.
04/23/18
MSCO
04/23/18
NO CHANGE
MSCO
DOJ eSim probe could be positive for smaller carriers, says Morgan Stanley
After the New York Times reported that the Justice Department has opened an investigation into potential collusion by AT&T (T), Verizon (VZ) and the GSMA to hinder the deployment of eSIM technology, Morgan Stanley analyst Simon Flannery said the news could be seen as a potential positive for the smaller carriers if the DoJ takes steps to make it easier for consumers to switch wireless carriers. He believes both T-Mobile (TMUS) and Sprint (S) would see an opportunity to take market share if eSIMs were introduced more broadly, Flannery tells investors.
04/25/18
RHCO
04/25/18
UPGRADE
Target $58
RHCO
Buy
Verizon upgraded to Buy at SunTrust on more stable fundamentals and valuation
As reported earlier, SunTrust analyst Greg Miller upgraded Verizon (VZ) to Buy from Hold and kept his $58 price target. Miller says that the latest Q1 results show the company's fundamentals are stabilizing as it addressed the headwinds in its market-leading core wireless business with its premium offering while it continues to invest in its network edge. The analyst also believes the company's valuation providing "more downside protection" than its closest rival AT&T (T), which faces greater legacy headwinds and M&A risk.
KEX Kirby
$82.95

-1.85 (-2.18%)

01/22/18
WELS
01/22/18
UPGRADE
Target $83
WELS
Outperform
Kirby upgraded to Outperform with $83 price target at Wells Fargo
Wells Fargo analyst Michael Webber upgraded Kirby to Outperform from Market Perform and raised his price target for the shares to $83 from $61. The analyst sees an improving risk/reward profile with the company's inland comps getting "considerably easier" in 2018 while its tax rate could drop to 25% from 37%. The sector has moved "far enough along in its trough that upside potential from even a modest cyclical recovery outweighs downside risks," Webber tells investors in a research note.
02/01/18
EVER
02/01/18
UPGRADE
EVER
Outperform
Kirby upgraded to Outperform from In Line at Evercore ISI
04/05/18
STFL
04/05/18
INITIATION
Target $88
STFL
Buy
Kirby resumed with a Buy at Stifel
Stifel analyst Benjamin Nolan resumed coverage of Kirby resumed with a Buy rating and $88 price target, saying he sees the company as well positioned to benefit from a recovering inland barge market and strong demand for fracking equipment.
03/29/18
OTRG
03/29/18
UPGRADE
OTRG
Positive
Kirby upgraded to Positive from Mixed at OTR Global
OTR Global upgraded Kirby to Positive from Mixed following checks that indicate improved utilization rates during Q1 and an uptick in barge spot prices.
GG Goldcorp
$13.97

-0.38 (-2.65%)

11/30/17
SBSH
11/30/17
UPGRADE
Target $16
SBSH
Buy
Goldcorp upgraded to Buy from Neutral at Citi
Citi analyst Alexander Hacking upgraded Goldcorp to Buy and raised his price target for the shares to $16 from $15. The multi-year underperformance of the shares has reset investor expectations and "opened up value," Hacking tells investors i a research note. The analyst remains "neutral to cautious" on the gold sector heading into 2018.
04/23/18
ADAM
04/23/18
UPGRADE
ADAM
Buy
Goldcorp upgraded to Buy from Hold at Canaccord
01/15/18
FBCO
01/15/18
UPGRADE
Target $19
FBCO
Outperform
Goldcorp upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Anita Soni upgraded Goldcorp to Outperform and raised her price target for the shares to $19 from $15.50. The shares closed Friday up 45c, or 3%, to $14.35. Soni sees Goldcorp posting "attractive" growth over the next two years and believes its analyst day on January 16 will serve as a positive catalyst for the shares. The analyst views the company's valuation as attractive relative to peers.
11/30/17
SBSH
11/30/17
DOWNGRADE
Target $13
SBSH
Sell
Barrick Gold downgraded to Sell from Buy at Citi
Citi analyst Alexander Hacking double downgraded Barrick Gold (ABX) to Sell from Buy and cut his price target for the shares to $13 from $20. The analyst cites the company's operating issues and potential for an upcoming reinvestment cycle. He remains "neutral to cautious" on the gold sector heading into 2018. Hacking this morning also upgraded Goldcorp (GG) to Buy and Agnico Eagle (AEM) to Neutral.
BMRN BioMarin
$81.41

0.33 (0.41%)

02/23/18
BMOC
02/23/18
NO CHANGE
Target $125
BMOC
Outperform
BMO ups BioMarin target to $125, sees upside from guidance
BMO Capital analyst Ian Somaiya last night raised his price target for shares of BioMarin Pharmaceutical to $125 from $119 following the company's Q4 results. The analyst cites better total revenue guidance, higher pricing of pegvaliase, and the benefit of tax reform for the target bump. He believes BioMarin's 2018 guidance provides upside while its pipeline markets. The analyst kept an Outperform rating on the shares.
02/23/18
STFL
02/23/18
NO CHANGE
Target $102
STFL
Buy
Scrutiny of BioMarin's pegvaliase likely to increase, says Stifel
Stifel analyst Stephen Willey said BioMarin's better than consensus forecast for its FY18 revenue keeps him confident in the fundamentals of its base business, though the "increasingly measured" commentary from management around pegvaliase's regulatory path/labeling and subsequent launch trajectory reinforces his lack of confidence in his longer-term pegvaliase estimates. He contends that the May 25, 2018 PDUFA date for pegvaliase has become of "heightened importance for investors," Willey told investors earlier. He lowered his price target on BioMarin shares to $102 from $105, largely to reflect a shallower pegvaliase launch trajectory, but keeps a Buy rating on the stock.
03/23/18
RHCO
03/23/18
NO CHANGE
Target $130
RHCO
Buy
SunTrust sees FDA report on children's ACH treatment as positive for BioMarin
SunTrust analyst Edward Nash writes that his review of the latest FDA briefing document released ahead of Adcom meeting discussing the drug development for the treatment of children with achondroplasia may be a positive for Biomarin. Nash notes that the company is "established as a leader in the space" and its current trial design with top-line Phase 3 data expected in late 2019 may exceed FDA expectations. The analyst keeps his Buy rating and a $130 price target on BioMarin.
04/09/18
JEFF
04/09/18
NO CHANGE
JEFF
Jefferies highlights other gene theraphy players after AveXis takeover
Novartis' (NVS) deal to acquire AveXis (AVXS) for $8.7B should remind investors about the ongoing attractiveness within smid-cap biotech, Jefferies analyst Michael Yee tells investors in a research note. Novartis' two large gene therapy deals in four months will lead to a question of "who's next," the analyst adds. Yee says other mid-late stage gene therapy players include Bluebird Bio (BLUE), Spark Therapeutics (ONCE), BioMarin (BMRN), Abeona Therapeutics (ABEO), Regenxbio (RGNX), Nightstar Therapeutics (NITE) and Voyager Therapeutics (VYGR).

TODAY'S FREE FLY STORIES

NVS

Novartis

$87.74

0.52 (0.60%)

, DBVT

DBV Technologies

$16.70

0.31 (1.89%)

04:55
11/18/18
11/18
04:55
11/18/18
04:55
Conference/Events
American College of Allergy, Asthma & Immunology to hold a meeting »

2018 ACAAI Meeting will…

NVS

Novartis

$87.74

0.52 (0.60%)

DBVT

DBV Technologies

$16.70

0.31 (1.89%)

REGN

Regeneron

$345.10

3.56 (1.04%)

SHPG

Shire

$175.59

-3.39 (-1.89%)

TEVA

Teva

$22.25

-0.37 (-1.64%)

SNY

Sanofi

$45.11

0.56 (1.26%)

GSK

GlaxoSmithKline

$40.35

-0.06 (-0.15%)

AZN

AstraZeneca

$40.67

-0.685 (-1.66%)

CHD

Church & Dwight

$65.42

-0.39 (-0.59%)

BSX

Boston Scientific

$37.22

0.75 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

  • 02

    Dec

  • 03

    Dec

  • 21

    Dec

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

PDVW

pdvWireless

$39.84

0.06 (0.15%)

16:30
11/17/18
11/17
16:30
11/17/18
16:30
Conference/Events
pdvWireless management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$57.49

0.23 (0.40%)

16:28
11/17/18
11/17
16:28
11/17/18
16:28
Conference/Events
CBS management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

THS

TreeHouse

$51.92

0.72 (1.41%)

, CAG

Conagra Brands

$33.09

0.66 (2.04%)

12:54
11/17/18
11/17
12:54
11/17/18
12:54
Periodicals
Treehouse Foods stock may have room to gain, Barron's says »

Treehouse Foods (THS)…

THS

TreeHouse

$51.92

0.72 (1.41%)

CAG

Conagra Brands

$33.09

0.66 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$194.23

1.83 (0.95%)

12:51
11/17/18
11/17
12:51
11/17/18
12:51
Periodicals
Amgen may be 'a remedy' for tougher times, Barron's says »

Amgen may be a stock that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

AAPL

Apple

$193.42

2 (1.04%)

, LITE

Lumentum

$41.50

0.46 (1.12%)

12:47
11/17/18
11/17
12:47
11/17/18
12:47
Periodicals
Apple stock could continue to slide, Barron's says »

Apple's (AAPL) stock…

AAPL

Apple

$193.42

2 (1.04%)

LITE

Lumentum

$41.50

0.46 (1.12%)

QRVO

Qorvo

$66.32

1.18 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$56.39

0.9 (1.62%)

, RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

12:41
11/17/18
11/17
12:41
11/17/18
12:41
Periodicals
Investors may find bargains among oil, natural gas stocks, Barron's says »

Investors have been…

APC

Anadarko

$56.39

0.9 (1.62%)

RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

RDS.A

Royal Dutch Shell

$62.02

0.34 (0.55%)

XOM

Exxon Mobil

$78.99

0.81 (1.04%)

CVX

Chevron

$119.14

2.18 (1.86%)

BP

BP

$40.85

-0.3 (-0.73%)

EOG

EOG Resources

$105.21

3.57 (3.51%)

OXY

Occidental Petroleum

$73.32

0.71 (0.98%)

COG

Cabot Oil & Gas

$25.73

0.09 (0.35%)

EQT

EQT Corporation

$16.62

-0.55 (-3.20%)

HAL

Halliburton

$32.46

0.02 (0.06%)

SLB

Schlumberger

$48.24

0.17 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Jan

  • 22

    Jan

LB

L Brands

$35.28

-0.41 (-1.15%)

, JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

12:34
11/17/18
11/17
12:34
11/17/18
12:34
Periodicals
Kohl's, Target set to thrive this holiday season, Barron's says »

Store chains have been…

LB

L Brands

$35.28

-0.41 (-1.15%)

JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

TJX

TJX

$51.47

-0.98 (-1.87%)

BBY

Best Buy

$66.41

-1.34 (-1.98%)

TIF

Tiffany

$106.48

0.52 (0.49%)

HD

Home Depot

$177.11

-0.25 (-0.14%)

TGT

Target

$79.67

-1.09 (-1.35%)

KSS

Kohl's

$72.48

-0.7 (-0.96%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 05

    Dec

  • 03

    Mar

T

AT&T

$30.30

0.18 (0.60%)

, FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

09:18
11/17/18
11/17
09:18
11/17/18
09:18
OnTheFly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

T

AT&T

$30.30

0.18 (0.60%)

FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

FOXA

21st Century Fox

$48.18

-0.11 (-0.23%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

CMCSA

Comcast

$38.60

0.11 (0.29%)

CMCSK

Comcast

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$16.46

-0.12 (-0.72%)

F

Ford

$9.05

-0.26 (-2.79%)

GM

General Motors

$35.76

0.21 (0.59%)

HMC

Honda

$28.21

0.01 (0.04%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$116.87

-0.02 (-0.02%)

VLKAY

Volkswagen

$0.00

(0.00%)

NYT

New York Times

$26.30

-0.2 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Dec

  • 04

    Dec

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

NVS

Novartis

$87.74

0.52 (0.60%)

, DBVT

DBV Technologies

$16.70

0.31 (1.89%)

04:55
11/17/18
11/17
04:55
11/17/18
04:55
Conference/Events
American College of Allergy, Asthma & Immunology to hold a meeting »

2018 ACAAI Meeting will…

NVS

Novartis

$87.74

0.52 (0.60%)

DBVT

DBV Technologies

$16.70

0.31 (1.89%)

REGN

Regeneron

$345.10

3.56 (1.04%)

SHPG

Shire

$175.59

-3.39 (-1.89%)

TEVA

Teva

$22.25

-0.37 (-1.64%)

SNY

Sanofi

$45.11

0.56 (1.26%)

GSK

GlaxoSmithKline

$40.35

-0.06 (-0.15%)

AZN

AstraZeneca

$40.67

-0.685 (-1.66%)

CHD

Church & Dwight

$65.42

-0.39 (-0.59%)

BSX

Boston Scientific

$37.22

0.75 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

  • 02

    Dec

  • 03

    Dec

  • 21

    Dec

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

MSI

Motorola Solutions

$129.97

0.72 (0.56%)

18:48
11/16/18
11/16
18:48
11/16/18
18:48
Hot Stocks
Motorola Solutions: ITC confirms Hytera products infringe Motorola patents »

Motorola Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Dec

  • 19

    Dec

PCG

PG&E

$24.39

6.62 (37.25%)

18:23
11/16/18
11/16
18:23
11/16/18
18:23
Periodicals
CPUC isn't ruling out board shuffle, breakup for PG&E, Bloomberg says »

The California Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$13.04

0.05 (0.38%)

18:00
11/16/18
11/16
18:00
11/16/18
18:00
Periodicals
Barrick Gold looking to add more copper, bullion assets, Reuters reports »

Barrick Gold is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTR

Aqua America

$33.05

0.165 (0.50%)

17:57
11/16/18
11/16
17:57
11/16/18
17:57
Hot Stocks
Aqua America CEO acquires over 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRE

Real Estate SPDR

$33.45

0.445 (1.35%)

, XLB

S&P Select Materials SPDR

$55.23

0.53 (0.97%)

17:39
11/16/18
11/16
17:39
11/16/18
17:39
General news
Week ending ETF scorecard: Real Estate leads, Consumer Discretionary slumps »

S&P500 SECTORS: Real…

XLRE

Real Estate SPDR

$33.45

0.445 (1.35%)

XLB

S&P Select Materials SPDR

$55.23

0.53 (0.97%)

XLU

Utilities SPDR

$54.86

0.77 (1.42%)

XLI

Industrial Select Sector SPDR

$72.00

(0.00%)

XLV

Health Care Select Sector SPDR

$92.05

0.91 (1.00%)

XLF

Financial Select Sector

$26.78

0.03 (0.11%)

XLP

Consumer Staples Sector SPDR

$56.04

0.15 (0.27%)

XLE

Energy Select Sector SPDR

$67.23

0.76 (1.14%)

XLC

Communication Services Select Sector SPDR Fund

$44.88

-0.2 (-0.44%)

XLK

Technology Select Sector SPDR

$68.22

-0.1 (-0.15%)

XLY

Consumer Discretionary Sector SPDR

$106.37

-0.43 (-0.40%)

GLD

SPDR Gold Shares

$115.56

0.82 (0.71%)

SLV

iShares Silver Trust

$13.55

0.115 (0.86%)

USO

United States Oil Fund

$12.07

0.08 (0.67%)

UNG

United States Natural Gas Fund

$35.43

3.63 (11.42%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$83.24

-0.27 (-0.32%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$111.73

0.23 (0.21%)

TLT

iShares 20+ Year Treasury Bond Fund

$114.65

0.61 (0.53%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.13

0.3 (0.30%)

SHY

iShares 1-3 Year Treasury Bond

$83.13

0.08 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$17.02

0.23 (1.37%)

17:36
11/16/18
11/16
17:36
11/16/18
17:36
Hot Stocks
Aquestive receives CRL from FDA for tadalafil oral film »

Aquestive Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

DAKT

Daktronics

$7.67

0.07 (0.92%)

17:35
11/16/18
11/16
17:35
11/16/18
17:35
Hot Stocks
Daktronics adopts new shareholder rights agreement »

Daktronics announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

TI

Telecom Italia

$6.02

0.12 (2.03%)

17:33
11/16/18
11/16
17:33
11/16/18
17:33
Periodicals
Gubitosi viewed as frontrunner for Telecom Italia CEO job, Reuters says »

Veteran Italian manager…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$18.77

-0.59 (-3.05%)

17:30
11/16/18
11/16
17:30
11/16/18
17:30
Hot Stocks
Maxar Technologies shareholders approve U.S. domestication »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUG

Plug Power

$1.83

(0.00%)

17:28
11/16/18
11/16
17:28
11/16/18
17:28
Syndicate
Breaking Syndicate news story on Plug Power »

Plug Power files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSB

GlobalSCAPE

$4.55

-0.02 (-0.44%)

17:22
11/16/18
11/16
17:22
11/16/18
17:22
Syndicate
Breaking Syndicate news story on GlobalSCAPE »

GlobalSCAPE files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQIX

Equinix

$388.18

2.67 (0.69%)

17:19
11/16/18
11/16
17:19
11/16/18
17:19
Hot Stocks
Equinix's Lee sells 2,792 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

LMT

Lockheed Martin

$301.06

-4.42 (-1.45%)

17:17
11/16/18
11/16
17:17
11/16/18
17:17
Hot Stocks
Lockheed Martin awarded $282.09M Naval Sea Systems Command contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLGT

Teligent

$2.56

0.045 (1.79%)

17:16
11/16/18
11/16
17:16
11/16/18
17:16
Hot Stocks
Teligent receives notification of deficiency from Nasdaq »

Teligent said that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAF

Staffing 360 Solutions

$1.82

0.07 (4.00%)

17:16
11/16/18
11/16
17:16
11/16/18
17:16
Syndicate
Breaking Syndicate news story on Staffing 360 Solutions »

Staffing 360 Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.